YTHDF2 and hepatocellular carcinoma: OGT-mediated O-GlcNAcylation of YTHDF2 enhanced its protein stability and oncogenic activity by inhibiting YTHDF2 ubiquitination and then promoted HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner [47].